HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George Olt Selected Research

Platinum Compounds (Compounds, Platinum)

9/2003Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George Olt Research Topics

Disease

2Carcinoma (Carcinomatosis)
12/2004 - 09/2003
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2004 - 08/2002
1Ovarian Neoplasms (Ovarian Cancer)
12/2004
1Residual Neoplasm
12/2004
1Disease Progression
09/2003
1Neutropenia
08/2002
1Neoplasms (Cancer)
04/2002
1Endometrial Neoplasms (Endometrial Cancer)
04/2002

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
12/2004 - 09/2003
3Paclitaxel (Taxol)FDA LinkGeneric
12/2004 - 09/2003
1Platinum Compounds (Compounds, Platinum)IBA
09/2003
1NSC 366140 (pyrazoloacridine)IBA
08/2002
1RetinoidsIBA
04/2002
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2002
1EnzymesIBA
04/2002

Therapy/Procedure

1Cytoreduction Surgical Procedures
12/2004
1Drug Therapy (Chemotherapy)
12/2004
1Therapeutics
09/2003
1Drug Tapering
08/2002